Toxicological Research

Korean Society of Toxicology & Korea Environmental Mutagen Society (한국독성학회)
권호 표지

Mutagenicity Studies on Nonspecific Immunostimulator BARODON®

비특이 면역증강제 BARODON®에 대한 유전독성시험

  • 서민수 (서울대학교 수의과대학 공중보건학교실) ;
  • 조성대 (서울대학교 수의과대학 공중보건학교실) ;
  • 안남식 (서울대학교 수의과대학 공중보건학교실) ;
  • 정지원 (서울대학교 수의과대학 공중보건학교실) ;
  • 양세란 (서울대학교 수의과대학 공중보건학교실) ;
  • 박준석 (서울대학교 수의과대학 공중보건학교실) ;
  • 박기수 (서울대학교 수의과대학 공중보건학교실) ;
  • 홍인선 (서울대학교 수의과대학 공중보건학교실) ;
  • 조은혜 (서울대학교 수의과대학 공중보건학교실)
  • Published : 2003.06.01
Download PDF
⟨ Previous Next ⟩

Abstract

A nonspecific immunostimulator $BARODON^{\circledR}$ was tested for mutagenicity using Ames Salmonella tester strains TA98, TA1 00, TA 102, TA 1535 and TA 1537 with or without metabolic activation (59 mix). None of the fresh species showed mutagenicity. In the reverse mutation test using Salmonella phimurium TA98, TA100, TA102, TA1535 and TA1537 did not increase the number of revertants at all doses tested (5, 2.5 or 1.25 mg/ml). Chromosome aberration test was carried out in Chinese hamster lung (CHL) cell line. The cells were treated with $BARODON^{\circledR}$ (1, 0.5 or 0.25 mg/ml), while positive control group was treated with Mitomycin C (0.1 mg/ml). The results show that there is no statistically significant difference between positive control and treatment groups. In mouse micronucleus test, there was significant increase in the ratio of micronucleated polychromatic erythrocyte (MNPCE) in the high dose group (10% $BARODON^{\circledR}$), while there is no significance between control and low (2.5% $BARODON^{\circledR}$) or middle (5% $BARODON^{\circledR}$ dose groups. Taken together, this results suggest that below 5% $BARODON^{\circledR}$ might not have mutagenic potential in vitro and vivo systems.

Keywords

References

  1. Comparing groups-catedorical data : Practical stastics for Medical Research Altman,D.G.
  2. Livest. Prod. Sci. v.59 Residues of antimicrobial drugs and feed additives in animal products; regulatory aspects Anadon,A.;Martinez-Larranage,M.R. https://doi.org/10.1016/S0301-6226(99)00026-3
  3. Trends Microbiol v.6 Probiotics, prebiotics or conbiotics Berg,R.D. https://doi.org/10.1016/S0966-842X(98)01224-4
  4. Livest. prod. Sci. v.59 Biotechnology in animal nutrition, physiology and health Bonneau,M.;Laarveld,B. https://doi.org/10.1016/S0301-6226(99)00029-9
  5. Environ. Mutagens Carcinogens v.21 Genotoxocity studies of the complex of acriflavine and guanosine Chung,Y.S.;Hong,E.K.;Kim,S.G.Ahn,E.T.;Lee,K.Y.;Kang,J.K.
  6. Environ. Mol. Mutagen. v.13 A procedure for data analysis of the rodent micronucleus test involving a historical control Hayashi,M.;Yoshmura,I.;Sofuni T.;lshdate,M.Jr. https://doi.org/10.1002/em.2850130412
  7. Mutat. Res. v.48 Chromosome tests with 134 compounds on Chinese hamster cells in vitro-ascreening for chemical carcinogens Ishidate,M.Jr.;Odashima,S. https://doi.org/10.1016/0027-5107(77)90177-4
  8. Environ. Mol. Mutagen. v.14 Chromosomal aberrations and sister chromatid exchange tests in Chinese hamster ovary cells in vitro, IV. Results with 15 chemicals Ivett,J.L.;Brown,B.M.;Rodgers,C.;Anderson,B.E.;Resnick,M.A.;Zeiger,E. https://doi.org/10.1002/em.2850140306
  9. J. Toxicol. Pub. Health v.18 Study on local irritation in rabbits and micronucleus test in mice with YHB216 Kang,M.J.;Kim,M.Y.;Park,M.K.;Kim,B.T.;Ahn,K.K.;Choi,Y.S.;Moon,B.S.;Lee,J.W.
  10. Environ. Mutagens Carcinogens v.16 Genotoxic evaluation of recombinant human erythopoietin (rHu-EPO) in short-term assays Kim,H.S.;Kwack,S.J.;Chun,S.A.;Lim,S.Y.;Ahn,Y.;Kim,W.B.;Kim,B.M.;Ahn,B.O.;Suh,D.S.;Lee,B.M.
  11. Iyakuhin Kenkyu v.24 Mutagenicity studies of S-1108, a new estertupe oral cephem anticiotic (IV): Microncleus teat in mouse bone-marrow cells Kondo,K.
  12. Seoul Univ. J. Vet. v.23 Enhancement of host immune responses by addition of nonspecific immunostimulator ($BARODON^？$) in animal feed Park,Y.H.;Woo,H.J.;Rhee,J.C.;Han,J.H.;Choi,S.I.;Yoo,B.W.;Kim,K.Y.
  13. Mutat. Res. v.74 Towards an improved micronucleus test: Studies on 3 model agents, mitomycin C, cyclophosphamide and dimethylbenzanthracene Salamore,M. https://doi.org/10.1016/0165-1161(80)90193-4
  14. Mutat. Res. v.31 The micronucleus test Schmid,W. https://doi.org/10.1016/0165-1161(75)90058-8
  15. New drug targets in inflammation and immunomodulation. D.D.T. v.3 Terance,H.;Alan,L.;David,W.
  16. J. Swine Health Prod. v.10 Immunostimulatory effects of an anionic alkali mineral complex solution ($BARODON^？$) on porcine lymphocytes Yoo,B.W.;Choi,S.l.;Kim,S.H.;Yang,S.J.;Koo,H.C.;Kwon,N.H.;Seo,S.H.;Park,B.K.;Yoo,H.S.;Park,Y.H.